The Business Times

Stocks to watch: Keppel Infra Trust, Boustead Projects, iX Biopharma, Raffles Medical, Wee Hur

Published Wed, Jun 2, 2021 · 08:48 AM

THE following companies saw new developments that may affect trading of their securities on Wednesday:

A7RU: The trustee-manager of Keppel Infrastructure Trust (KIT) on Tuesday proposed to issue S$300 million 4.3 per cent subordinated perpetual securities, under its S$2 billion multicurrency debt issuance programme. Net proceeds will be used to refinance borrowings of KIT as well as finance general working capital purposes, capital expenditure and investments of the trust. Its units closed unchanged at S$0.55 on Tuesday, before the announcement.

AVM : AVM 0%: The real estate player announced on Wednesday that its wholly-owned subsidiary, BP-Vietnam Development (BP-VD) has signed an option agreement with Khai Toan Joint Stock Company (KTG). KTG will provide BP-VD with a call option to purchase 49 per cent of the issued and paid-up share capital of the holding company (KBJSC) for KTG and Boustead Industrial Logistics Joint Stock Company, while BP-VD will provide KTG with a put option to sell 49.0 per cent of the issued and paid-up share capital of KBJSC to BP-VD. BP-VD will pay an option deposit to KTG in three tranche payments totalling 289.25 billion dong (S$16.6 million). Shares of Boustead Projects closed flat at S$1.19 on Tuesday.

42C: The speciality pharmaceutical company on Wednesday said it installed new freeze-dry equipment that will enable the expansion of its wafer production capacity by up to six times. The company is on track to produce its first commercial batch of wafers in July 2021, it said in its bourse filing, and it expects to benefit from improved operational efficiency and economies of scale. Shares of the company closed one Singapore cent or 4.1 per cent down at 23.5 cents on Tuesday.

BSL: The private medical provider has partnered a subsidiary of China Life Insurance (Group) to boost collaborations in China's healthcare market, as part of its continued expansion there, it said in a joint statement on Tuesday. Both parties will look at initiatives across several areas, including collaborations in the provision of medical services, healthcare management, training and development as well as healthcare financing through insurance, with a focus on supporting ageing populations. Shares of Raffles Medical closed trading at S$1.15 on Tuesday, up S$0.01 or 0.9 per cent.

E3B: The mainboard-listed company, through its wholly-owned unit Wee Hur Construction, has secured a new project worth S$176.7 million from the Housing and Development Board, it said on Tuesday. It is not expected to have a material impact on the consolidated net tangible assets per share and consolidated earnings per share of the group for FY2021. Shares of Wee Hur closed flat at 20.5 Singapore cents on Tuesday.

GET BT IN YOUR INBOX DAILY

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

VIEW ALL

Z74: In a bourse filing, the telco said it has appointed former manpower minister, Lim Swee Say, as a non-executive independent director in the group. Mr Lim, 66, was Singapore's minister for manpower from 2015 to 2018. At present, he holds various positions such as NTUC trustee, chairman of the NTUC Administration and Research Unit's board of trustees. He is also deputy chairman of the Singapore Labour Foundation. Shares in Singtel ended Tuesday 0.8 per cent or S$0.02 up at S$2.43.

U96: On Tuesday before market open, it announced the appointment of Tow Heng Tan, current chief executive of private equity firm Pavilion Capital, as a non-executive, non-independent director and a member of the board's executive committee. Pavilion Capital is a unit of Temasek Holdings. Mr Tow is currently a director on the boards of several companies, including Fullerton Financial Holdings, Keppel Capital, National Healthcare Group and ABC World Asia. Sembcorp shares closed at S$2.22, down 0.5 per cent or S$0.01.

BVA: The glove maker's plan to list in Hong Kong and raise up to US$1 billion has been delayed as it seeks to resolve a US import ban on its products, said sources with direct knowledge of the matter. In July 2020, the Malaysian company faced a US ban on imports on its products imposed due to forced labour concerns. Top Glove flagged in April it would sell 793.5 million shares in the listing, half what it proposed in its application to the Hong Kong bourse in February. Its shares closed on Tuesday at S$1.63, down S$0.02 or 1.2 per cent.

KEYWORDS IN THIS ARTICLE

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Capital Markets & Currencies

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here